M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer.
The centre will leverage fully automated lesion segmentation in PSMA-PET/CT imaging. Malaysia’s Sunway Medical Centre, Sunway ...
These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...
PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and ...
Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...
Telix Pharmaceuticals Limited today announces that it has received a positive decision on the Marketing Authorization ...